期刊文献+

结直肠癌肝转移的手术治疗 被引量:2

Surgical treatment of liver metastases from colorectal cancer
下载PDF
导出
摘要 目的 探讨手术治疗结直肠癌肝转移的疗效以及影响因素.方法 收集74例手术治疗的结直肠癌肝转移病例,进行回顾性分析.结果 本组患者3年和5年生存率分别为63.8%和49.8%.原发灶淋巴结转移者5年生存率(33.3%)显著低于无转移者(63.7%,P=0.002),脉管侵犯者(39.6%)显著低于无侵犯者(61.6%,P=0.025).转移灶个数≤3个者(53.7%)显著高于>3个者(34.6%,P=0.021).肝转移灶局限于半肝者,其5年生存率(65.2%)显著高于双侧弥漫者(23.9%,P=0.001).结论 手术切除是唯一可能治愈结直肠癌肝转移的方法.原发灶无淋巴结转移、无脉管侵犯,转移灶个数不超过3个、局限于半肝者预后较好. Objective To assess the efficacy and influencing factors of surgical treatment of liver metastases from colorcctal cancer. Methods The clinical data of 74 patients who underwent hepatectomy for colorectal liver metastases were collected and analyzed retrospectively. Results The 3 - and 5 - year survival rate after hepatectomy for metastases was 63.8% and 49.8% ,respectively. The 5 - year survival rate was significantly lower in patients with lymph node metastases from the primary site than that without metastases (33.3% vs 63.7% ,P = 0. 002). Survival rate in patients with microvessel invasion from the primary tumor was also significantly lower than that without invasion (39.6% vs 61.6% , P = 0.025). Patients with metastases 〈 or = 3 had longer 5 - year survival (53.7%) than that 〉 3 (34.6% ,P =0. 021 ). The survival in patients who had metastases isolated to half liver was longer than that in patients who had diffused metastases (65.2% vs 23.9% ,P = 0. 001 ). Conclusion Surgical re- section may be the only treatment modality for the cure of colorectal liver metastases. Without lymph node metastases and microvessel invasion from the primary tumor,and metastases 〈 or = 3 and isolated to half liver are associated with better prognosis.
出处 《临床外科杂志》 2009年第9期615-617,共3页 Journal of Clinical Surgery
关键词 结直肠肿瘤 肝转移 手术 预后 colorectal neoplasms liver metastasis surgical operation prognosis
  • 相关文献

参考文献7

  • 1Koshariya M,Jagad RB,Kawamoto J,et al.An update and our experience with metastatic liver disease[J].Hepatogastroenterology,2007,54(80):2232-2239.
  • 2Pawlik TM,Scoggins CR,Zorzi D,et al.Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases[J].Ann Surg,2005,241(5):715-722,discussion 722-714.
  • 3Wang X,Hershman DL,Abrams JA,et al.Predictors of survival after hepatic resection among patients with colorectal liver metastasis[J].Br J Cancer,2007,97(12):1606-1612.
  • 4Tsai M,Su Y,Ho M,et al.Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastases[J].Ann Surg Oncol,2007,14(2):786-794.
  • 5Hughes KS,Simon R,Songhorabodi S,et al.Resection of the liver for colorectal carcinoma metastases:a multi-institutional study of patterns of recurrence[J].Surgery,1986,100(2):278-284.
  • 6Vauthey JN,Zorzi D,Pawlik TM.Making unresectable hepatic colorectal metastases resectable-does it work[J]?Semin Oncol,2005,32(Suppl 9):S118-122.
  • 7Liska V,Treska V,Holubec L,et al.Recurrence of colorectal liver metastases after surgical treatment:multifactorial study[J].Hepatogastroenterology,2007,54(78):1741-1744.

同被引文献25

  • 1周岩冰,江海涛,周晓斌,张建立,王海波,毛伟征,丁连安,张敬智,于冠君.直肠癌手术的质量控制[J].青岛大学医学院学报,2006,42(2):95-98. 被引量:6
  • 2吴韬,刘斌,杨世昆,郑南.结直肠癌肝转移的手术治疗探讨[J].医学新知,2007,17(1):20-21. 被引量:1
  • 3KEMENY N. Presurgical chemotherapy in patients being considered for liver resection[J]. Oncolologist, 2007,12(7) :825- 839.
  • 4秦新裕.结直肠癌肝转移的综合治疗进展[C].全国肿瘤转移学会大会论文集,2007:7-8.
  • 5GREGORY D L, BARUCH B, NACY E K. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from eoloreetal earcinoma[J]. J Clin Oncol, 2005,23(9):2038-2048.
  • 6CAPUSSOTTI L, FERRERO A, VIGANO L, et al. Major liver resections synchronous with colorectal surgery[J]. Ann Surg Oneol, 2007,14(1) :195-201.
  • 7MALIK H Z, HAMADY Z Z, ADAIR R, et al. Prognostic influence of multiple hepatic metastases from colorectal cancer [J]. Eur J Surg Oncol, 2007,33 (4) :468-473.
  • 8Choi JS,Kim KH,Jeon YK. Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues[J].{H}International Journal of Cancer,2009,(06):1258-1262.
  • 9Benarroch EE. ADAM proteins,their ligands,and clinical implications[J].{H}NEUROLOGY,2012,(12):914-920.
  • 10Seals DF,Courtneidge SA. The ADAMs family of metalloproteases:multidomain proteins with multiple functions[J].{H}Genes and development,2003,(01):7-30.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部